We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dietary Supplements And FDA: Potential For Partnership?

Law360 (March 7, 2018, 1:15 PM EST) -- On Aug. 18, 2017, dietary supplement ingredient supplier ChromaDex filed a citizen petition requesting that the U.S. Food and Drug Administration “investigate and take appropriate remedial action” against Elysium Health Inc., which markets the dietary supplement Basis. The petition, filed against a backdrop of bicoastal litigation between Elysium and ChromaDex, alleges that samples of Elysium’s Basis dietary supplement contained an industrial solvent, toluene, at 94-144 milligrams per kilogram (mg/kg), and also contained lead and molybdenum.[1] The citizen petition and its assertions were surprising and unexpected, especially...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.